Pediatric Vaccines Market Analysis By Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate), By Application (Infectious Diseases, Cancer, Allergy), By Region, And Segment Forecasts, 2014 - 2025
This report can be delivered to the clients within 48 Hours
The global pediatric vaccines market is expected to reach USD 60.4 billion by 2025 at an 11.7% CAGR, according to a new report by Grand View Research, Inc. Advancements in development of vaccines and new product launches are some of the major drivers of the market.
Increase in investments by companies to capture a larger market share is anticipated to propel growth. Some of the factors attributed to increase in investment are high growth prospects in the emerging market, immunization schedule mandated by doctors for children, and awareness programs led by UNICEF, WHO, and other healthcare organizations. Furthermore, increase in number of government initiatives for raising awareness about immunization is expected to boost the market for pediatric vaccines.
Advancements in development of novel adjuvants and therapeutic vaccines are expected to drive growth during the forecast period. Ongoing research in novel molecules targeted at specific mechanisms of action in the body is aimed at providing immunity against fatal diseases such as cancer and Zika virus disease. For instance, in June 2016, Inovio Pharmaceuticals, Inc. announced the initiation of phase I clinical trial for their Zika DNA vaccine named GLS-5700.
Further key findings from the report suggest:
The global pediatric vaccines market is expected to reach USD 60.4 billion by 2025 at an 11.7% CAGR, according to a new report by Grand View Research, Inc. Advancements in development of vaccines and new product launches are some of the major drivers of the market.
Increase in investments by companies to capture a larger market share is anticipated to propel growth. Some of the factors attributed to increase in investment are high growth prospects in the emerging market, immunization schedule mandated by doctors for children, and awareness programs led by UNICEF, WHO, and other healthcare organizations. Furthermore, increase in number of government initiatives for raising awareness about immunization is expected to boost the market for pediatric vaccines.
Advancements in development of novel adjuvants and therapeutic vaccines are expected to drive growth during the forecast period. Ongoing research in novel molecules targeted at specific mechanisms of action in the body is aimed at providing immunity against fatal diseases such as cancer and Zika virus disease. For instance, in June 2016, Inovio Pharmaceuticals, Inc. announced the initiation of phase I clinical trial for their Zika DNA vaccine named GLS-5700.
Further key findings from the report suggest:
- The global pediatric vaccines market was estimated at USD 22.4 billion in 2016 and is expected to grow with a CAGR of 11.7% from 2017 to 2025
- By type, monovalent emerged as the largest segment due to factors such as high usage and increase in initiatives for R&D activities supported by various governments
- Conjugate vaccines formed the dominant technology segment in terms of revenue in 2016. Higher adoption of these vaccines and increase in prevalence of infectious diseases contribute to its lead in the market for pediatric vaccines
- By application, the cancer segment is expected to witness the fastest growth with a CAGR of 12.6% owing to increasing prevalence of cancer and rising need for immunization against the disease
- North America held the largest revenue share in 2016. Its dominance in the market for pediatric vaccines is owing to factors such as local presence of major players in the industry and extensive R&D activities
- The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increase in prevalence of infectious diseases and a large target population
- Key players such as GlaxoSmithKline plc; Pfizer, Inc.; SANOFI; and AstraZeneca dominated the global market for pediatric vaccines in 2016.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic Scope & Assumptions
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.2 Market Size and Growth Prospects
3.2.1 Market driver analysis
3.2.1.1 Rise in importance and awareness of immunization across the globe
3.2.1.2 High predominance of chronic diseases
3.2.1.3 Technologic advancements in the types of vaccines
3.2.1.4 Increase in government and nongovernment funding.
3.2.2 Market restraint analysis
3.2.2.1 Cost of immunization
3.2.2.2 Lack of healthcare infrastructure
3.3 Penetration & Growth Prospect Mapping
3.4 Pediatric Vaccines - SWOT Analysis, by Factor (Political & legal, economic and technological)
3.5 Industry Analysis - Porter’s
3.6 Pipeline Analysis
CHAPTER 4 PEDIATRIC VACCINES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1 Vaccines Market: Vaccine Type Movement Analysis
4.2 Monovalent Vaccines
4.2.1 Monovalent vaccines market, 2014 - 2025 (USD Billion)
4.3 Multivalent Vaccines
4.3.1 Multivalent vaccines market, 2014 - 2025 (USD Billion)
CHAPTER 5 PEDIATRIC VACCINES MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1 Pediatric Vaccines Market: Vaccine Technology Movement Analysis
5.2 Live Attenuated Vaccines
5.2.1 Live attenuated vaccines market, 2014 - 2025 (USD Billion)
5.3 Inactivated Vaccines
5.3.1 Inactivated vaccines market, 2014 - 2025 (USD Billion)
5.4 Subunit Vaccines
5.4.1 Subunit vaccines market, 2014 - 2025 (USD Billion)
5.5 Toxoid Vaccines
5.5.1 Toxoid vaccines market, 2014 - 2025 (USD Billion)
5.6 Conjugate Vaccines
5.6.1 Conjugate vaccines market, 2014 - 2025 (USD Billion)
5.7 Others
5.7.1 Other vaccines market, 2014 - 2025 (USD Billion)
CHAPTER 6 PEDIATRIC VACCINES MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1 Pediatric Vaccines Market: Application Movement Analysis
6.2 Infectious Diseases
6.2.1 Infectious diseases market, 2014 - 2025 (USD Billion)
6.3 Cancer
6.3.1 Cancer market, 2014 - 2025 (USD Billion)
6.4 Allergy
6.4.1 Allergy market, 2014 - 2025 (USD Billion)
CHAPTER 7 PEDIATRIC VACCINES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE & APPLICATION
7.1 Pediatric Vaccines Market Share by Region, 2015 & 2025
7.2 North America
7.2.1 North America vaccines market, 2014 - 2025 (USD Billion)
7.2.2 U.S.
7.2.2.1 U.S pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.2.3 Canada
7.2.3.1 Canada pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.3 Europe
7.3.1 Europe pediatric vaccines market, 2014 - 2025 (USD Billion)
7.3.2 Germany
7.3.2.1 Germany pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.3.3 UK
7.3.3.1 UK pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.4 Asia Pacific
7.4.1 Asia Pacific pediatric vaccines market, 2014 - 2025 (USD Billion)
7.4.2 China
7.4.2.1 China pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.4.3 Japan
7.4.3.1 Japan pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.4.4 India
7.4.4.1 India pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.5 Latin America
7.5.1 Latin America pediatric vaccines market, 2014 - 2025 (USD Billion)
7.5.2 Brazil
7.5.2.1 Brazil pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.5.3 Mexico
7.5.3.1 Mexico pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.6 MEA
7.6.1 MEA pediatric vaccines market, 2014 - 2025 (USD Billion)
7.6.2 South Africa
7.6.2.1 South Africa pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 GlaxoSmithKline plc (GSK)
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 Merck Sharp & Dohme Corp.
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 SANOFI
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 AstraZeneca
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Pfizer, Inc.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Zydus Cadila
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Indian Immunologicals Limited
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Mitsubishi Tanabe Pharma Corporation
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Serum Institute of India Pvt. Ltd.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Panacea Biotec
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 Sinovac Biotech Ltd.
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 Bio Med Pvt. Ltd.
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic Scope & Assumptions
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation & Scope
3.2 Market Size and Growth Prospects
3.2.1 Market driver analysis
3.2.1.1 Rise in importance and awareness of immunization across the globe
3.2.1.2 High predominance of chronic diseases
3.2.1.3 Technologic advancements in the types of vaccines
3.2.1.4 Increase in government and nongovernment funding.
3.2.2 Market restraint analysis
3.2.2.1 Cost of immunization
3.2.2.2 Lack of healthcare infrastructure
3.3 Penetration & Growth Prospect Mapping
3.4 Pediatric Vaccines - SWOT Analysis, by Factor (Political & legal, economic and technological)
3.5 Industry Analysis - Porter’s
3.6 Pipeline Analysis
CHAPTER 4 PEDIATRIC VACCINES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1 Vaccines Market: Vaccine Type Movement Analysis
4.2 Monovalent Vaccines
4.2.1 Monovalent vaccines market, 2014 - 2025 (USD Billion)
4.3 Multivalent Vaccines
4.3.1 Multivalent vaccines market, 2014 - 2025 (USD Billion)
CHAPTER 5 PEDIATRIC VACCINES MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1 Pediatric Vaccines Market: Vaccine Technology Movement Analysis
5.2 Live Attenuated Vaccines
5.2.1 Live attenuated vaccines market, 2014 - 2025 (USD Billion)
5.3 Inactivated Vaccines
5.3.1 Inactivated vaccines market, 2014 - 2025 (USD Billion)
5.4 Subunit Vaccines
5.4.1 Subunit vaccines market, 2014 - 2025 (USD Billion)
5.5 Toxoid Vaccines
5.5.1 Toxoid vaccines market, 2014 - 2025 (USD Billion)
5.6 Conjugate Vaccines
5.6.1 Conjugate vaccines market, 2014 - 2025 (USD Billion)
5.7 Others
5.7.1 Other vaccines market, 2014 - 2025 (USD Billion)
CHAPTER 6 PEDIATRIC VACCINES MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1 Pediatric Vaccines Market: Application Movement Analysis
6.2 Infectious Diseases
6.2.1 Infectious diseases market, 2014 - 2025 (USD Billion)
6.3 Cancer
6.3.1 Cancer market, 2014 - 2025 (USD Billion)
6.4 Allergy
6.4.1 Allergy market, 2014 - 2025 (USD Billion)
CHAPTER 7 PEDIATRIC VACCINES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE & APPLICATION
7.1 Pediatric Vaccines Market Share by Region, 2015 & 2025
7.2 North America
7.2.1 North America vaccines market, 2014 - 2025 (USD Billion)
7.2.2 U.S.
7.2.2.1 U.S pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.2.3 Canada
7.2.3.1 Canada pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.3 Europe
7.3.1 Europe pediatric vaccines market, 2014 - 2025 (USD Billion)
7.3.2 Germany
7.3.2.1 Germany pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.3.3 UK
7.3.3.1 UK pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.4 Asia Pacific
7.4.1 Asia Pacific pediatric vaccines market, 2014 - 2025 (USD Billion)
7.4.2 China
7.4.2.1 China pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.4.3 Japan
7.4.3.1 Japan pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.4.4 India
7.4.4.1 India pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.5 Latin America
7.5.1 Latin America pediatric vaccines market, 2014 - 2025 (USD Billion)
7.5.2 Brazil
7.5.2.1 Brazil pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.5.3 Mexico
7.5.3.1 Mexico pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
7.6 MEA
7.6.1 MEA pediatric vaccines market, 2014 - 2025 (USD Billion)
7.6.2 South Africa
7.6.2.1 South Africa pediatric vaccines estimates and forecasts, 2014 - 2025 (USD Billion)
CHAPTER 8 COMPETITIVE LANDSCAPE
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 GlaxoSmithKline plc (GSK)
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 Merck Sharp & Dohme Corp.
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 SANOFI
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 AstraZeneca
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Pfizer, Inc.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Zydus Cadila
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Indian Immunologicals Limited
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Mitsubishi Tanabe Pharma Corporation
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 Serum Institute of India Pvt. Ltd.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Panacea Biotec
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 Sinovac Biotech Ltd.
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 Bio Med Pvt. Ltd.
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives
LIST OF TABLES
Table 1 Country share estimation
Table 2 North America pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 3 North America pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 4 North America pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 5 Percent of children aged 19-35 months receiving vaccination (2015)
Table 6 U.S. pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 7 U.S. pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 8 U.S. pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 9 Decline rate in children’s health (2017)
Table 10 Canada pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 11 Canada pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 12 Canada pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 13 Europe pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 14 Europe pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 15 Europe pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 16 Germany pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 17 Germany pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 18 Germany pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 19 U.K. pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 20 U.K. pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 21 U.K. pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 22 Asia Pacific pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 23 Asia Pacific pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 24 Asia Pacific pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 25 China pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 26 China pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 27 China pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 28 Japan pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 29 Japan pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 30 Japan pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 31 India pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 32 India pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 33 India pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 34 Latin America pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 35 Latin America pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 36 Latin America pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 37 Brazil pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 38 Brazil pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 39 Brazil pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 40 Mexico pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 41 Mexico pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 42 Mexico pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 43 MEA pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 44 MEA pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 45 MEA pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 46 South Africa pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 47 South Africa pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 48 South Africa pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 49 List of Market Players
Table 1 Country share estimation
Table 2 North America pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 3 North America pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 4 North America pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 5 Percent of children aged 19-35 months receiving vaccination (2015)
Table 6 U.S. pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 7 U.S. pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 8 U.S. pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 9 Decline rate in children’s health (2017)
Table 10 Canada pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 11 Canada pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 12 Canada pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 13 Europe pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 14 Europe pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 15 Europe pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 16 Germany pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 17 Germany pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 18 Germany pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 19 U.K. pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 20 U.K. pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 21 U.K. pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 22 Asia Pacific pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 23 Asia Pacific pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 24 Asia Pacific pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 25 China pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 26 China pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 27 China pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 28 Japan pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 29 Japan pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 30 Japan pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 31 India pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 32 India pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 33 India pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 34 Latin America pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 35 Latin America pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 36 Latin America pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 37 Brazil pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 38 Brazil pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 39 Brazil pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 40 Mexico pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 41 Mexico pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 42 Mexico pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 43 MEA pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 44 MEA pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 45 MEA pediatric pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 46 South Africa pediatric vaccines market, by type, 2014 - 2025 (USD Billion)
Table 47 South Africa pediatric vaccines market, by application, 2014 - 2025 (USD Billion)
Table 48 South Africa pediatric vaccines market, by technology, 2014 - 2025 (USD Billion)
Table 49 List of Market Players
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Value chain based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market summary
Fig. 6 Market trends & outlook
Fig. 7 Market segmentation & scope
Fig. 8 The global pediatric vaccines market, 2014-2025 (USD Billion)
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Worldwide immunization coverage: 2016 (in %)
Fig. 11 Market restrain relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 SWOT Analysis, by factor (Political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Pediatric vaccines market type outlook key takeaways
Fig. 16 Pediatric vaccines market: Application movement analysis
Fig. 17 Global monovalent pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 18 Global multivalent pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 19 Pediatric vaccines market technology outlook key takeaways
Fig. 20 Pediatric vaccines market: Technology movement analysis
Fig. 21 Global live attenuated pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 22 Global inactivated pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 23 Global subunit pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 24 Global toxoid pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 25 Global conjugate pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 26 Global other pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 27 Pediatric vaccines market application outlook: Key takeaways
Fig. 28 Pediatric vaccines market: Application movement analysis
Fig. 29 Global infectious diseases market, 2014 - 2025 (USD Billion)
Fig. 30 Global cancer market, 2014 - 2025 (USD Billion)
Fig. 31 Global allergy market, 2014 - 2025 (USD Billion)
Fig. 32 Regional market place: Key takeaways
Fig. 33 Pediatric vaccines market: Regional movement analysis
Fig. 34 North America pediatric vaccines market,2014 - 2025 (USD Billion)
Fig. 35 Measles Cases per Year (2010 - 2016)
Fig. 36 Europe pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 37 Asia Pacific pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 38 Latin America pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 39 MEA pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 40 Strategy framework
Fig. 41 Participant categorization
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Value chain based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market summary
Fig. 6 Market trends & outlook
Fig. 7 Market segmentation & scope
Fig. 8 The global pediatric vaccines market, 2014-2025 (USD Billion)
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Worldwide immunization coverage: 2016 (in %)
Fig. 11 Market restrain relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 SWOT Analysis, by factor (Political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Pediatric vaccines market type outlook key takeaways
Fig. 16 Pediatric vaccines market: Application movement analysis
Fig. 17 Global monovalent pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 18 Global multivalent pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 19 Pediatric vaccines market technology outlook key takeaways
Fig. 20 Pediatric vaccines market: Technology movement analysis
Fig. 21 Global live attenuated pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 22 Global inactivated pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 23 Global subunit pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 24 Global toxoid pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 25 Global conjugate pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 26 Global other pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 27 Pediatric vaccines market application outlook: Key takeaways
Fig. 28 Pediatric vaccines market: Application movement analysis
Fig. 29 Global infectious diseases market, 2014 - 2025 (USD Billion)
Fig. 30 Global cancer market, 2014 - 2025 (USD Billion)
Fig. 31 Global allergy market, 2014 - 2025 (USD Billion)
Fig. 32 Regional market place: Key takeaways
Fig. 33 Pediatric vaccines market: Regional movement analysis
Fig. 34 North America pediatric vaccines market,2014 - 2025 (USD Billion)
Fig. 35 Measles Cases per Year (2010 - 2016)
Fig. 36 Europe pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 37 Asia Pacific pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 38 Latin America pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 39 MEA pediatric vaccines market, 2014 - 2025 (USD Billion)
Fig. 40 Strategy framework
Fig. 41 Participant categorization
